ASTEC718.10

Astec LifeSciences Limited

· Chemicals
₹ CrorePeersPUNJABCHEMMOLIPLINSECTICIDDHARMAJBHARATRASADVANCEHERANBAMcap ₹1,600 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)224.21234.39186.29186.29
Receivable Days (DSO)134.63141.14201.76201.76
Payable Days (DPO)102.21119.70118.31111.35
Cash Conversion Cycle (days)256.63255.83269.74276.70
Working Capital Turnover343.82-15.52-7.89-7.76
Asset Turnover0.470.430.480.48
Cash Conversion (CFO/Net Income)-0.220.061.001.00
CFO/EBITDA-1.730.1317.8317.83
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.